Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$98.98 - $115.74 $172,621 - $201,850
1,744 Added 28.79%
7,801 $902,000
Q2 2023

Aug 14, 2023

SELL
$96.34 - $112.38 $267,054 - $311,517
-2,772 Reduced 31.4%
6,057 $622,000
Q1 2023

May 15, 2023

SELL
$107.32 - $113.5 $8.55 Million - $9.04 Million
-79,685 Reduced 90.03%
8,829 $963,000
Q4 2022

Feb 21, 2023

SELL
$62.39 - $113.8 $107 Million - $196 Million
-1,719,050 Reduced 95.1%
88,514 $10.1 Million
Q3 2022

Nov 14, 2022

SELL
$58.92 - $84.67 $2.65 Million - $3.81 Million
-45,054 Reduced 2.43%
1,807,564 $112 Million
Q2 2022

Aug 15, 2022

SELL
$79.4 - $116.36 $6.72 Million - $9.85 Million
-84,649 Reduced 4.37%
1,852,618 $148 Million
Q1 2022

May 16, 2022

BUY
$86.42 - $109.81 $15.4 Million - $19.6 Million
178,354 Added 10.14%
1,937,267 $204 Million
Q4 2021

Feb 11, 2022

BUY
$98.56 - $119.91 $13.1 Million - $15.9 Million
132,842 Added 8.17%
1,758,913 $190 Million
Q3 2021

Nov 12, 2021

BUY
$91.91 - $110.37 $5.06 Million - $6.08 Million
55,058 Added 3.5%
1,626,071 $178 Million
Q2 2021

Aug 13, 2021

BUY
$86.24 - $95.92 $135 Million - $150 Million
1,561,546 Added 16494.62%
1,571,013 $147 Million
Q4 2020

Feb 16, 2021

BUY
$67.0 - $84.39 $81,070 - $102,111
1,210 Added 14.65%
9,467 $693,000
Q2 2020

Aug 11, 2020

SELL
$30.2 - $56.98 $31,498 - $59,430
-1,043 Reduced 11.22%
8,257 $459,000
Q4 2019

Feb 14, 2020

BUY
$25.43 - $36.67 $236,499 - $341,031
9,300 New
9,300 $337,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.